CAS 376348-65-1
:Maraviroc
Description:
Maraviroc is a chemokine receptor antagonist primarily used as an antiretroviral medication for the treatment of HIV infection. It specifically targets the CCR5 receptor on the surface of immune cells, preventing the virus from entering and infecting these cells. Maraviroc is characterized by its selective inhibition of CCR5-tropic HIV strains, making it effective in patients whose viral strains utilize this receptor for entry. The compound is typically administered orally and is known for its relatively favorable side effect profile compared to other antiretroviral agents. Its mechanism of action involves blocking the interaction between HIV and the CCR5 receptor, thereby reducing viral load and improving immune function. Maraviroc is often used in combination with other antiretroviral drugs to enhance treatment efficacy and is subject to specific resistance patterns, necessitating prior testing for CCR5 tropism before initiation of therapy. As with any medication, monitoring for potential adverse effects and drug interactions is essential during treatment.
Formula:C29H41F2N5O
InChI:InChI=1/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1
InChI key:InChIKey=GSNHKUDZZFZSJB-QYOOZWMWSA-N
SMILES:C(C[C@H](NC(=O)C1CCC(F)(F)CC1)C2=CC=CC=C2)N3[C@@]4(C[C@@H](C[C@]3(CC4)[H])N5C(C(C)C)=NN=C5C)[H]
Synonyms:- 4,4-Difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]cyclohexanecarboxamide
- 4,4-Difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide
- UK 427857
- Maraviroc
- Celsentri
- Cyclohexanecarboxamide, 4,4-difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]-
- 4,4-difluoro-N-[(1S)-3-{(1R,5S)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl}-1-phenylpropyl]cyclohexanecarboxamide
- 4,4-difluoro-N-[(1S)-3-{3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl}-1-phenylpropyl]cyclohexanecarboxamide
- Maraviroc(UK427857)
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 10 products.
Cyclohexanecarboxamide,4,4-difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]-
CAS:Formula:C29H41F2N5OPurity:98%Color and Shape:SolidMolecular weight:513.6655Ref: IN-DA00I7ET
1gTo inquire5gTo inquire1mg54.00€5mg54.00€25mg129.00€50mg153.00€100mg172.00€250mg339.00€4,4-Difluoro-N-((S)-3-((1R,3R,5S)-3-(3-Isopropyl-5-Methyl-4H-1,2,4-Triazol-4-Yl)-8-Azabicyclo[3.2.1]Octan-8-Yl)-1-Phenylpropyl)Cyclohexane-1-Carboxamide
CAS:4,4-Difluoro-N-((S)-3-((1R,3R,5S)-3-(3-Isopropyl-5-Methyl-4H-1,2,4-Triazol-4-Yl)-8-Azabicyclo[3.2.1]Octan-8-Yl)-1-Phenylpropyl)Cyclohexane-1-CarboxamidePurity:99.5%Molecular weight:513.67g/molMaraviroc
CAS:Formula:C29H41F2N5OPurity:≥ 97.0%Color and Shape:White to off-white crystalline powderMolecular weight:513.67Maraviroc
CAS:Formula:C29H41F2N5OPurity:>95.0%(HPLC)(qNMR)Color and Shape:White to Light yellow powder to crystalMolecular weight:513.67Maraviroc
CAS:Maraviroc: a CCR5 antagonist blocking HIV-1 entry; IC50s—MIP-1α: 3.3nM, MIP-1β: 7.2nM, RANTES: 5.2nM.Formula:C29H41F2N5OPurity:97.13% - 99.59%Color and Shape:Brown SolidMolecular weight:513.67Maraviroc
CAS:Controlled ProductFormula:C29H41F2N5OColor and Shape:White To Off-WhiteMolecular weight:513.67Maraviroc
CAS:<p>CCR-5 chemokine receptor antagonist; inhibits HIV entry via gp120 protein</p>Formula:C29H41F2N5OPurity:Min. 95%Color and Shape:PowderMolecular weight:513.67 g/mol








